Active targeting co-delivery of therapeutic Sur siRNA and an antineoplastic drug via epidermal growth factor receptor-mediated magnetic nanoparticles for synergistic programmed cell death in glioblastoma stem cells-Reference-Cited by-同舟云学术

Active targeting co-delivery of therapeutic Sur siRNA and an antineoplastic drug via epidermal growth factor receptor-mediated magnetic nanoparticles for synergistic programmed cell death in glioblastoma stem cells

Published:2020 Issue:2 Volume:4 Page:574-588
ISSN:2052-1537
Container-title:Materials Chemistry Frontiers
language:en
Short-container-title:Mater. Chem. Front.

Author:

Wang Xueqin¹²³⁴^ORCID,Li Ruifang¹²³⁴,Zhu Yongxia⁵⁶⁴,Wang Zichao¹²³⁴,Zhang Huiru¹²³⁴,Cui Liuqing¹²³⁴,Duan Shaofeng⁷⁸⁹⁴,Guo Yuqi⁵⁶⁴

Affiliation:

1. College of Bioengineering

2. Henan University of Technology

3. Zhengzhou

4. P. R. China

5. Henan Provincial People's Hospital

6. Zhengzhou 450003

7. School of Pharmacy

8. Henan University

9. Kaifeng

Abstract

An EGFR-targeted theranostic composite, and targeted co-delivery of therapeutic siRNAs and DOX for glioblastoma stem cell treatments.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Henan University

Henan University of Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/QM/C9QM00666D

Reference51 articles.

1. Progress in glioma diagnosis, classification and treatment

2. Surgical oncology for gliomas: the state of the art

3. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251

4. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression

5. Effect of siRNA-Livin on drug resistance to chemotherapy in glioma U251 cells and CD133+ stem cells

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities;International Journal of Biological Macromolecules;2024-05

2. Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment;Advanced Healthcare Materials;2024-03-07

3. Inorganic nanocarriers for siRNA delivery for cancer treatments;Biomedical Materials;2024-01-16

4. Personalized Nanoparticles for Cancer Therapy;Personalized and Precision Nanomedicine for Cancer Treatment;2024

5. Nanoscale metal-organic frameworks for the delivery of nucleic acids to cancer cells;International Journal of Pharmaceutics: X;2023-12